Infertility Treatment Market

Cooper Companies Inc. (US) and Cook Group Incorporated (US) are the Major Players in the Infertility Treatment Market

The global infertility treatment market size is projected to reach USD 2.2 billion by 2026 from USD 1.5 billion in 2021, at a CAGR of 8.1 % during the forecast period. The decline in the fertility rate, increase awareness about the availability of infertility treatment procedures, rising number of fertility clinics, increasing public & private investments and growing technological advancements are expected to drive market growth in the coming years

Some of the prominent players operating in the global infertility treatment market include The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), MedGyn Products, Inc. (US), DxNow, Inc. (US), Nidacon International AB (Sweden), Gynotec B.V. (Netherlands), SAR Healthline Pvt. Ltd. (India), and InVitroCare Inc. (US).

To know about the assumptions considered for the study download the pdf brochure 

The analysis of market developments between 2018 and 2021 revealed that several growth strategies such as research collaborations and partnerships were adopted by market players to strengthen their product portfolios and maintain a competitive position in the infertility treatment market

THE COOPER COMPANIES, INC. 

The Cooper Companies operates through two business units, namely, CooperVision (CVI) and CooperSurgical (CSI). The company offers a wide range of products and services focused on women’s health, fertility, and diagnostics through its CooperSurgical business segment. This business unit markets its products under various brand names, such as ORIGIO (provides in vitro fertilization (IVF) products), Reprogenetics (provides genetic testing solutions), and LifeGlobal (providing media products as well as IVF laboratory air filtration products). Through offering a broad range of innovative technologies and services to clinicians and patients worldwide, the company aims to further strengthen its position in the market, by pursuing the strategy of acquisitions.

The company commercializes its products in over 100 countries and has its presence across the US, Europe, and the RoW. Some of its major subsidiaries include CooperVision International Holding Company (UK), Ocular Sciences SAS (France), CooperSurgical, Inc. (US), CooperSurgical Holdings Ltd. (UK), Cooper Medical, Inc. (US), The Cooper Companies Global Holdings LP (UK), Research Instruments Ltd. (UK), and TCC Holdings S.a.r.l (Luxembourg).

COOK GROUP

Cook Group is one of the leading companies in the field of medical device manufacturing. The company offers a wide range of infertility treatment devices and has a significant market presence globally. Cook focuses on strengthening its market position by adopting growth strategies such as expansions and collaborations. Cook Group has its new state-of-the-art distribution center in Singapore, which caters to the growing demands across India, Taiwan, and Thailand. Cook has its sales and marketing offices all over the globe, and its production facilities are based in Limerick (Ireland) and Canton (US). The company’s notable subsidiaries include Cook Ltd. (UK), Sabin Corporation (US), Cook Vascular Incorporated (US), William Cook Europe ApS (Denmark), and Cook Medical Incorporated (US). The company primarily operates in Australia, Canada, Denmark, Ireland, and the US and distributes its products in 135 countries.

VITROLIFE

Vitrolife develops, manufactures, and markets instruments, systems, and cultivation media related to assisted reproduction techniques. The company offers a wide range of products for various procedures, such as sperm preparation, oocyte retrieval, conventional IVF, ICSI, embryo culture, embryo transfer, vitrification, and slow freezing. Vitrolife is one of the first companies to dispense IVF laboratories with high standard ready-to-use culture media. The company operates under one business unit—Fertility segment—which develops, produces, and markets nutrient solutions (media), products for cryopreservation, and advanced disposable instruments such as needles and pipettes, as well as offers the time-lapse technology for assisted reproduction.

HAMILTON THORNE LTD.

Hamilton Thorne designs, manufactures, and distributes precision laser devices and advanced image analysis systems for the fertility, stem cell, and development biology research markets. The company offers its products and services under three major brands, namely, Hamilton Thorne, Gynemed, and Embryotech Laboratories. The company has a wide customer base, including university research centers, fertility clinics, animal breeding facilities, pharmaceutical companies, and biotechnology companies. The company’s CASA (Computer Assisted Sperm Analysis) image analysis systems offer efficient and reliable studies of reproductive cells in the field of human fertility. With the aim to maintain its share in the infertility treatment market, the company is focusing on inorganic strategies such as acquisitions to expand its product portfolio and increase its revenue in this market.

FUJIFILM

FUJIFILM Irvine Scientific a wholly owned subsidiary of FUJIFILM Holdings Corporation provides a wide range of innovative products in life sciences and medical media to assist advances in customer healthcare. The company also focuses on manufacturing reagents, and medical devices for researchers and clinicians working in cell therapy & regenerative medicine, assisted reproductive technology & cytogenetics, and industrial cell culture for the large-scale production of biotherapeutics and vaccines.

The company has its manufacturing facilities in the US and Japan and exports its products across Asia, Europe, South America, Africa, and the Middle East.

Related Reports:

Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure (ART (IVF,ICSI, Surrogate), Insemination, Laparoscopy, Hysteroscopy, Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Research) - Global Forecast to 2026

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Infertility Treatment Market Size,  Share & Growth Report
Report Code
MD 3765
RI Published ON
10/18/2021
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status